효소면역측정법(ELISA) : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Enzyme-Linked Immunosorbent Assay (ELISA) was estimated to be worth US$ 1791 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Enzyme-Linked Immunosorbent Assay (ELISA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.

The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.

Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.

This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enzyme-Linked Immunosorbent Assay (ELISA) by region & country, by Type, and by Application.

The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).

Market Segmentation

By Company

• Thermo Fisher Scientific
• Enzo Life Sciences
• BioLegend
• Merck
• Bio-Techne
• BD Biosciences
• Bio-Rad Laboratorie
• Aviva Systems Biology
• Repligen
• Lifespan Biosciences
• PerkinElmer
• BioVision
• Innovative Research
• Biomatik
• Shanghai Kehua Bio-Engineering
• Biomerieux

Segment by Type

• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA
• Others

Segment by Application

• Laboratory
• Testing Institutions
• Hospital
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Enzyme-Linked Immunosorbent Assay (ELISA) Product Introduction
• 1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast
  • 1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2020-2031)
  • 1.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume (2020-2031)
  • 1.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Price (2020-2031)
• 1.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends & Drivers
  • 1.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
  • 1.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers & Opportunity
  • 1.3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Challenges
  • 1.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Revenue Ranking (2024)
• 2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (2020-2025)
• 2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Sales Volume Ranking (2024)
• 2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Company Players (2020-2025)
• 2.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Enzyme-Linked Immunosorbent Assay (ELISA) Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Enzyme-Linked Immunosorbent Assay (ELISA)
• 2.9 Enzyme-Linked Immunosorbent Assay (ELISA) Market Competitive Analysis
  • 2.9.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Enzyme-Linked Immunosorbent Assay (ELISA) Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Indirect ELISA
  • 3.1.2 Sandwich ELISA
  • 3.1.3 Competitive ELISA
  • 3.1.4 Others
• 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type
  • 3.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Type (2020-2031)
  • 3.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Type (%) (2020-2031)
• 3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type
  • 3.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Laboratory
  • 4.1.2 Testing Institutions
  • 4.1.3 Hospital
  • 4.1.4 Others
• 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application
  • 4.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Application (2020-2031)
  • 4.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Application (%) (2020-2031)
• 4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application
  • 4.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region
  • 5.1.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2020-2025)
  • 5.1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2026-2031)
  • 5.1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), (2020-2031)
• 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region
  • 5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2020-2025)
  • 5.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2026-2031)
  • 5.2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (%), (2020-2031)
• 5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 5.4.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 5.5.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 5.7.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.3.2 United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.4.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.5.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.6.2 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.7.2 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
  • 6.9.2 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Thermo Fisher Scientific
  • 7.1.1 Thermo Fisher Scientific Company Information
  • 7.1.2 Thermo Fisher Scientific Introduction and Business Overview
  • 7.1.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.1.5 Thermo Fisher Scientific Recent Development
• 7.2 Enzo Life Sciences
  • 7.2.1 Enzo Life Sciences Company Information
  • 7.2.2 Enzo Life Sciences Introduction and Business Overview
  • 7.2.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.2.5 Enzo Life Sciences Recent Development
• 7.3 BioLegend
  • 7.3.1 BioLegend Company Information
  • 7.3.2 BioLegend Introduction and Business Overview
  • 7.3.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.3.5 BioLegend Recent Development
• 7.4 Merck
  • 7.4.1 Merck Company Information
  • 7.4.2 Merck Introduction and Business Overview
  • 7.4.3 Merck Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Merck Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.4.5 Merck Recent Development
• 7.5 Bio-Techne
  • 7.5.1 Bio-Techne Company Information
  • 7.5.2 Bio-Techne Introduction and Business Overview
  • 7.5.3 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.5.5 Bio-Techne Recent Development
• 7.6 BD Biosciences
  • 7.6.1 BD Biosciences Company Information
  • 7.6.2 BD Biosciences Introduction and Business Overview
  • 7.6.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.6.5 BD Biosciences Recent Development
• 7.7 Bio-Rad Laboratorie
  • 7.7.1 Bio-Rad Laboratorie Company Information
  • 7.7.2 Bio-Rad Laboratorie Introduction and Business Overview
  • 7.7.3 Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.7.5 Bio-Rad Laboratorie Recent Development
• 7.8 Aviva Systems Biology
  • 7.8.1 Aviva Systems Biology Company Information
  • 7.8.2 Aviva Systems Biology Introduction and Business Overview
  • 7.8.3 Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.8.5 Aviva Systems Biology Recent Development
• 7.9 Repligen
  • 7.9.1 Repligen Company Information
  • 7.9.2 Repligen Introduction and Business Overview
  • 7.9.3 Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.9.5 Repligen Recent Development
• 7.10 Lifespan Biosciences
  • 7.10.1 Lifespan Biosciences Company Information
  • 7.10.2 Lifespan Biosciences Introduction and Business Overview
  • 7.10.3 Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.10.5 Lifespan Biosciences Recent Development
• 7.11 PerkinElmer
  • 7.11.1 PerkinElmer Company Information
  • 7.11.2 PerkinElmer Introduction and Business Overview
  • 7.11.3 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.11.5 PerkinElmer Recent Development
• 7.12 BioVision
  • 7.12.1 BioVision Company Information
  • 7.12.2 BioVision Introduction and Business Overview
  • 7.12.3 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.12.5 BioVision Recent Development
• 7.13 Innovative Research
  • 7.13.1 Innovative Research Company Information
  • 7.13.2 Innovative Research Introduction and Business Overview
  • 7.13.3 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.13.5 Innovative Research Recent Development
• 7.14 Biomatik
  • 7.14.1 Biomatik Company Information
  • 7.14.2 Biomatik Introduction and Business Overview
  • 7.14.3 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.14.5 Biomatik Recent Development
• 7.15 Shanghai Kehua Bio-Engineering
  • 7.15.1 Shanghai Kehua Bio-Engineering Company Information
  • 7.15.2 Shanghai Kehua Bio-Engineering Introduction and Business Overview
  • 7.15.3 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.15.5 Shanghai Kehua Bio-Engineering Recent Development
• 7.16 Biomerieux
  • 7.16.1 Biomerieux Company Information
  • 7.16.2 Biomerieux Introduction and Business Overview
  • 7.16.3 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • 7.16.5 Biomerieux Recent Development

8 Industry Chain Analysis

• 8.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industrial Chain
• 8.2 Enzyme-Linked Immunosorbent Assay (ELISA) Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Enzyme-Linked Immunosorbent Assay (ELISA) Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Enzyme-Linked Immunosorbent Assay (ELISA) Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer